Promoted Content Promoted Content

X

Market Place

Market Place

Menu

Menu

Post Enquiry

Post Enquiry

PharmaCompass

Home

Market Place

Market Place

Search

    Find

    • Active Pharmaceutical Ingredients Active Pharmaceutical Ingredients
    • Finished Drug Formulations Finished Drug Formulations
    • Price Prices
    • Excipients Excipients
    • Services Services
    • Market Place Marketplace

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry

    Find Clinical Drug Development Pipelines & Deals | PipelineProspector

    Loading...

    All Data

    Filters Filter refresh
    ×
    FILTER DATA :
    News Type filter
      Company filter
        Product Type filter
          Deal Size filter
            Upfront Payment filter
              refresh

              Product Type Full Screen

              Companies Full Screen

              Grunenthal

              • Deals

              Virtual BoothOur shared vision is to have a World, free of Pain.

              GERMANY Germany

              Contact Supplier Contact Supplier

              Virtual Booth Virtual Booth

              Virtual Innovation Day

              Participation Not Confirmed

              Update your events

              Grünenthal Closes a Deal with Teva to Market Teriparatide

              Contact the Supplier

              Lead Product(s): Teriparatide

              Therapeutic Area: Musculoskeletal Product Name: Tetridar

              Highest Development Status: Approved Product Type: Peptide

              Partner/Sponsor/Collaborator: Teva Pharmaceutical Industries

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Agreement September 18, 2020

              Details:

              Grünenthal and Teva have reached an exclusive agreement for the marketing, distribution, and promotion of teriparatide (Tetridar) in the Spanish market.

              Bayer AG

              • Deals

              Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

              GERMANY Germany

              Post An Enquiry Post An Enquiry

              Virtual Booth Virtual Booth

              Virtual Innovation Day

              Participation Not Confirmed

              Update your events

              Strategic Distribution Between Bayer Animal Health and Bioiberica in the International Companion Animal Health Market

              Contact the Supplier

              Lead Product(s): Chondroitin Sulfate,Glucosamine Sulfate,Hyaluronic Acid

              Therapeutic Area: Musculoskeletal Product Name: Condrovet

              Highest Development Status: Approved Product Type: Small molecule

              Partner/Sponsor/Collaborator: Bioiberica SA

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Agreement June 09, 2020

              Details:

              Under the terms of the agreement, Bayer Animal Health will distribute and market selected products from Bioiberica´s Companion Animal Health portfolio in eight countries.

              PharmaCompass__DigitalAd